Cargando…
Anti-ST2 Nanoparticle Alleviates Lung Inflammation by Targeting ILC2s-CD4(+)T Response
BACKGROUND: Asthma has been regarded as an inflammatory disease, and group 2 innate lymphoid cells (ILC2s) are implicated in asthma pathogenesis. However, no strategy is available to block ILC2s function. Efficiency is also limited due to the use of systemic or subcutaneous routes of administration....
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721292/ https://www.ncbi.nlm.nih.gov/pubmed/33299314 http://dx.doi.org/10.2147/IJN.S268282 |